Valuation: Asahi Kasei Corporation

Market Cap 2,110B 13.34B 11.9B 11.04B 10.05B 18.92B 1,268B 19.29B 132B 51.83B 661B 50.06B 49.01B P/E 2027 *
12.1x
P/E 2028 * 11.3x
Enterprise Value 2,768B 17.5B 15.61B 14.49B 13.19B 24.83B 1,664B 25.31B 173B 68.01B 867B 65.68B 64.3B EV / Sales 2027 *
0.84x
EV / Sales 2028 * 0.8x
Free-Float
96.37%
Yield 2027 *
2.92%
Yield 2028 * 3.23%
10-10 Asahi Kasei Therapeutics, Inc. Announces FDA Approval Of HOVILPRI Tablets Developed By AiCuris Anti-Infective Cures AG For Mucocutaneous HSV Lesions Refractory To Standard Antiviral Treatment In Immunocompromised Adults CI
10-09 US FDA approves Asahi Kasei's drug for persistent herpes infections RE
10-09 Japan's Nikkei limps to weekly loss as AI doubts, bond stress weigh RE
10-08 Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients CI
10-01 Teijin Frontier, Asahi Kasei Advance Merge to Form TA Frontier MT
10-01 Teijin Frontier Co., Ltd. concluded a basic agreement to acquire Asahi Kasei Advance Corporation from Asahi Kasei Corporation. CI
09-15 Asahi Kasei Bioprocess Unveils Vantij Su-Vfc Benchtop for Automated Single-Use Virus Filtration CI
09-14 Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan MT
08-26 Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company?s 40-Year North American Battery Separator Strategy CI
08-20 Asahi Kasei Develops Novel Lithium Pre-Doping Technology For Silicon-Rich Lithium-Ion Batteries CI
08-19 Asahi Kasei Expands Capacity For Water Electrolysis And Chlor-Alkali Equipment In Kawasaki CI
08-17 Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025. CI
08-13 Asahi Kasei Corporation's Equity Buyback announced on November 5, 2025, has closed with 22,859,400 shares, representing 1.69% for ¥39,999.9 million. CI
1 day-1.82%
1 week-5.83%
Current month-5.46%
1 month+0.77%
3 months-16.07%
6 months-0.41%
Current year+12.81%
1 week 1,555
Extreme 1555
1,619.5
1 month 1,555
Extreme 1555
1,681
Current year 1,415
Extreme 1415
1,906
1 year 1,157
Extreme 1157
1,906
3 years 880
Extreme 880
1,906
5 years 880
Extreme 880
1,906
10 years 606.1
Extreme 606.1
1,906
Manager TitleAgeSince
Director of Finance/CFO - -
President 67 01/04/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 01/04/2022
Director/Board Member 79 01/06/2018
Director/Board Member 67 01/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-5.83%+34.85%+67.34% 13.53B
-3.43%-4.35%+18.86%+32.87% 72.29B
+0.30%+2.81%+26.52%+25.17% 50.23B
+0.37%+1.11%+0.93%+22.36% 16.04B
+0.40%+5.23%+36.91%-9.55% 10.36B
-4.04%-3.35%+38.52%+25.94% 10.16B
+0.86%+8.38%+152.03%-2.00% 9.91B
+2.85%+4.53%+25.68% - 9.15B
-0.42%+1.17%-18.38%+10.11% 7.77B
-3.86%-4.82%+65.43%+35.02% 7.53B
Average -0.88%+0.88%+38.14%+23.03% 20.7B
Weighted average by Cap. -1.38%+0.57%+29.22%+27.28%

Financials

2027 *2028 *
Net sales 3,293B 20.82B 18.57B 17.23B 15.69B 29.54B 1,979B 30.1B 206B 80.9B 1,032B 78.13B 76.49B 3,383B 21.39B 19.08B 17.7B 16.12B 30.35B 2,033B 30.93B 211B 83.12B 1,060B 80.28B 78.59B
Net income 174B 1.1B 982M 911M 830M 1.56B 105B 1.59B 10.87B 4.28B 54.56B 4.13B 4.05B 186B 1.18B 1.05B 975M 888M 1.67B 112B 1.7B 11.63B 4.58B 58.38B 4.42B 4.33B
Net Debt 658B 4.16B 3.71B 3.45B 3.14B 5.91B 396B 6.02B 41.11B 16.18B 206B 15.63B 15.3B 594B 3.75B 3.35B 3.11B 2.83B 5.33B 357B 5.43B 37.06B 14.59B 186B 14.09B 13.79B
Projected Income Statement - Annual - Asahi Kasei Corporation
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
47,895
Date Price Change Volume
15/10/26 ¥1,567.00 -1.82% 4,578,000
14/10/26 ¥1,596.00 -0.13% 4,447,500
13/10/26 ¥1,598.00 +0.79% 4,207,500
09/10/26 ¥1,585.50 -3.94% 5,894,900
08/10/26 ¥1,650.50 -0.81% 4,223,700
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Asahi Kasei Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,567.00JPY
Average target price
1,940.83JPY
Spread / Average Target
+23.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Asahi Kasei Corporation
  1. Stock Market
  2. Stocks
  3. 3407 Stock